Managing Complications in CKD

Published: 25 February 2021

  • Views:

    Views Icon 21986
  • Likes:

    Heart Icon 4

Overview

Full programme

  • Views:

    Views Icon 21986
  • Likes:

    Heart Icon 4

Overview

This educational symposium was part of the eSPACE CRM meeting held on 22-24 January 2021.

 

The session focuses on novel therapies for Hyperkalaemia and Anaemia.

 

Espace CRM

This symposium was funded by an unrestricted educational grant from AstraZeneca.

Learning objectives

This educational symposium will allow the audience to:

  • Highlight the global burden of CKD and associated complications
  • Discuss the challenges in the current management paradigm for CKD and associated complications, such as RAASi optimisation and iron management
  • Review clinical and mechanistic evidence for the use of novel therapeutic interventions in treating hyperkalaemia and anaemia of CKD, in the context of traditional therapies

Symposium Agenda

Time - Session title and objective - Speaker(s)

  • 10 mins - Welcome and Introductions - Stephen Fishbone
  • 25 mins - Novel therapies for CKD complications: From evidence to practice - Adeera Levin (Canada) & Kieran McCafferty (UK)
  • 20 mins - Panel discussion an Q&A - All faculty, moderated by Stephen Fishbone
  • 5 mins - Future directions and Chair’s summary - All faculty

Series overview

Part 1

Welcome & Introductions

1 session

Part 2

Novel therapies for CKD complications: From evidence to practice

1 session

  • Novel therapies for CKD complications: From evidence to practice

    Watch now

Part 3

Panel discussion an Q&A

1 session

Part 4

Future directions and Chair’s summary

1 session

  • Future directions and Chair’s summary

    Watch now

Faculty biographies